Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter Study
Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter Study. // Journal of Cardiac Failure. – URL: https://www.sciencedirect.com/science/article/pii/S1071916426001132?dgcid=rss_sd_all
Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter Study. Journal of Cardiac Failure. https://www.sciencedirect.com/science/article/pii/S1071916426001132?dgcid=rss_sd_all
“Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter Study.” Journal of Cardiac Failure.
@article{article117036,
title = {Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter Study},
journal = {Journal of Cardiac Failure},
url = {https://www.sciencedirect.com/science/article/pii/S1071916426001132?dgcid=rss_sd_all}
}